These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2425953)

  • 21. Time-dependent apoptosis of alveolar macrophages from rats exposed to bleomycin: involvement of tnf receptor 2.
    Zhao HW; Hu SY; Barger MW; Ma JK; Castranova V; Ma JY
    J Toxicol Environ Health A; 2004 Sep; 67(17):1391-406. PubMed ID: 15371238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function correlations in the reaction of bis(thiosemicarbazonato) copper(II) complexes with Ehrlich ascites tumor cells.
    Minkel DT; Saryan LA; Petering DH
    Cancer Res; 1978 Jan; 38(1):124-9. PubMed ID: 563285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of combined treatments with low hyperthermia and bleomycin on survivals of murine L cells.
    Shioura H; Hayashi S; Matsumoto H; Kitai R; Ohtsubo T; Nishida T; Zhang SW; Yoshida M; Ishii Y; Kano E
    J Exp Clin Cancer Res; 1997 Jun; 16(2):147-52. PubMed ID: 9261739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prooxidative effect of copper--metallothionein in the acute cytotoxicity of hydrogen peroxide in Ehrlich ascites tumour cells.
    Suntres ZE; Lui EM
    Toxicology; 2006 Jan; 217(2-3):155-68. PubMed ID: 16221516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of combined treatment with 40 degrees C hyperthermia and bleomycin on the accumulation of heat shock protein in murine L cells.
    Jin ZH; Shioura H; Kano E; Hayashi S; Hatashita M; Matsumoto H; Ohtsubo T
    Int J Oncol; 2002 Jan; 20(1):137-42. PubMed ID: 11743654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative binding properties of metallobleomycins with DNA 10-mers.
    Li W; Zhao C; Xia C; Antholine WE; Petering DH
    Biochemistry; 2001 Jun; 40(25):7559-68. PubMed ID: 11412110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of bleomycin on cell survival and some implications for tumor therapy.
    Terasima T; Takabe Y; Watanabe M; Katsumata T
    Prog Biochem Pharmacol; 1976; 11():68-77. PubMed ID: 63972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular distribution of (14C)bleomycin and the cytokinetic effects of bleomycin in the mouse tumor.
    Fujimoto J; Higashi H; Kosaki G
    Cancer Res; 1976 Jul; 36(7 PT 1):2248-53. PubMed ID: 58717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis.
    Harrison JH; Lazo JS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1052-8. PubMed ID: 2462625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of reaction of DNA-bound Fe(III)bleomycin with ascorbate: interplay of specific and non-specific binding.
    Li W; Antholine WE; Petering DH
    J Inorg Biochem; 2002 May; 90(1-2):8-17. PubMed ID: 12009250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deglyco-peplomycin metal complexes on DNA fibers: a role of the sugar moiety for the stability and the orientation of the complexes.
    Iiyama T; Chikira M; Oyoshi T; Sugiyama H
    J Biol Inorg Chem; 2003 Jan; 8(1-2):135-40. PubMed ID: 12459908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cellular transport mechanisms for 57Co-bleomycin].
    Metelmann HR; Bier J; Bitter K
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):99-101. PubMed ID: 6157514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of labelled tallysomycin by solid Ehrlich ascites tumors in mice.
    Liniecki J; Rembelska M; Koniarek B
    Nuklearmedizin; 1983 Jun; 22(3):159-61. PubMed ID: 6194513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells.
    Nagai K; Nagasawa K; Sadzuka Y; Tsujimoto M; Takara K; Ohnishi N; Yokoyama T; Fujimoto S
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):244-50. PubMed ID: 11935217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of antitumor activity of ascorbate against Ehrlich ascites tumor cells by the copper:glycylglycylhistidine complex.
    Kimoto E; Tanaka H; Gyotoku J; Morishige F; Pauling L
    Cancer Res; 1983 Feb; 43(2):824-8. PubMed ID: 6293704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanism of action of bleomycin at the molecular level].
    Takita T
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2659-65. PubMed ID: 6210059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of carbohydrate moiety of bleomycin-A2 in caspase-3 activation and internucleosomal chromatin fragmentation in apoptosis of laryngeal carcinoma cells.
    Brahim S; Abid K; Kenani A
    Cell Biol Int; 2008 Feb; 32(2):171-7. PubMed ID: 17950632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromatin condensation and differential sensitivity of mammalian and insect cells to DNA strand breaks induced by bleomycin.
    López-Larraza DM; Padrón J; Ronci NE; Vidal Rioja LA
    Mutat Res; 2006 Aug; 600(1-2):93-101. PubMed ID: 16620879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleomycin hydrolase activity in pulmonary cells.
    Lazo JS; Merrill WW; Pham ET; Lynch TJ; McCallister JD; Ingbar DH
    J Pharmacol Exp Ther; 1984 Dec; 231(3):583-8. PubMed ID: 6209387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of hypoxia in anticancer drug-induced cytotoxicity for Ehrlich ascites cells.
    Gupta V; Costanzi JJ
    Cancer Res; 1987 May; 47(9):2407-12. PubMed ID: 2436764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.